Introduction
Material and methods
Results
MMV | MPP | ||||
---|---|---|---|---|---|
Mean | SD | Mean | SD | p-value | |
mFTA preop | 182.6 | 6.6 | 182.2 | 7.1 | 0.479 |
WOMAC pain preop | 48.7 | 21.0 | 49.7 | 20.8 | 0.3704 |
WOMAC stiffness preop | 54.4 | 25.9 | 52.3 | 25.4 | 0.3128 |
WOMAC function preop | 51.5 | 20.8 | 51.5 | 21.2 | 0.9060 |
WOMAC total preop | 51.6 | 20.0 | 51.2 | 19.7 | 0.9216 |
ROM preop (°) | 109.5 | 16.2 | 108.0 | 15.6 | 0.282 |
ROM day 4 (°) | 66.8 | 14.6 | 68.1 | 15.2 | 0.305 |
ROM day 10 (°) | 88.6 | 11.8 | 87.5 | 12.5 | 0.383 |
WOMAC pain 1 year | 15.7 | 18.9 | 17.2 | 20.1 | 0.6952 |
WOMAC stiffness 1 year | 23.1 | 21.8 | 25.0 | 23.7 | 0.5451 |
WOMAC function 1 year | 21.4 | 21.4 | 22.7 | 22.5 | 0.6734 |
WOMAC total 1 year | 20.1 | 19.6 | 21.6 | 20.9 | 0.6541 |
ROM 1 year (°) | 110.1 | 12.2 | 109.5 | 14.7 | 0.338 |
Discussion
Author | Year | n | Outcome parameters | FU periods | Results | Resumé |
---|---|---|---|---|---|---|
Aslam et al. [1] | 2017 | 42 vs. 42 | KSS, VAS, SLR, extensor lag, hospital stay, LRR rate, blood loss, patellar tracking | Day 1, 1 week, 1 month, 3 months, 6 months, 1 year | MMV: better KSS at 1 week and 1 month, earlier SLR, less LRR, shorter stay | Pro MMV |
Bäthis et al. [2] | 2005 | 25 vs. 25 | VAS, Q‑strength, proprioception | 3 weeks, 6 weeks | MMV: less pain, higher Q‑strength, no difference in ROM | Pro MMV |
Dalury and Jiranek [4] | 1999 | 24 vs. 24 | Q‑strength, VAS, SLR, ROM at discharge, radiographic outcome | 6 weeks, 12 weeks | MVV: higher Q‑strength at 6 and 12 weeks, less pain and earlier SLR | Pro MMV |
Dalury et al. [5] | 2008 | 20 vs. 20 | Radiograph, electromyography, nerve conduction studies, ROM tests, and KSS, VAS, hospital stay, blood loss, radiographic outcome | 6 weeks, 12 weeks | No difference | Equal |
Engh et al. [6] | 1997 | 61 vs. 57 | LRR rate, patellar tracking, Q‑strength, ROM, SLR | 6 weeks | No difference | Equal |
Gelfer et al. [10] | 2003 | 30 (both groups) | Patellar perfusion (bone scan), AKP, grind test, HSS | 2, 3, 6 weeks | No difference | Equal |
Keating et al. [14] | 1999 | 100 vs. 100 | LRR, ROM day 2, ROM at discharge, SLR, extensor lag | First weeks | No difference | Equal |
Layher et al. [17] | 2016 | 9 vs. 10 | 3D gait analysis (5 weeks, 6 months), KSS; WOMAC, SLR, STS, VAS, ROM at discharge, radiographic outcome | 5 weeks, 6 months | MMV: worse ROM at discharge, better sagittal knee moment (5 weeks) and knee power (5 weeks, 6 months), better WOMAC 6 months | Equal |
Maestro et al. [19] | 2000 | 25 vs. 17 | KSS, ROM, LRR rate, ROM, active knee extension | 1, 6, 12 months | MMV: less LRR, better active knee extension day 5, better ROM at discharge | Pro MMV |
Nutton et al. [20] | 2014 | 12 vs. 16 | Walking, stairs, SLR, stay, inpatient mobility milestones, knee kinematics, muscle strength, timed up and go, WOMAC, and daily step count, Q‑strength, SLR | 6 weeks, 3 months, 6 months | No difference: time to walking, stairs, SLR, discharge, timed up and go, WOMAC, ROM, extensor strength | Equal |
Shukla et al. [23] | 2017 | 24 vs. 28 | KSS; duration of hospital stay, blood loss | 2 weeks, 6 weeks, 3 months, 6 months, 1 year | MVV: better KSS 2 weeks, 6 weeks, 3 months | Pro MMV |
White et al. [25] | 1999 | 109 vs. 109 | Surgical time, LRR rate, and total blood loss. pain, ROM, SLR | Day 8, 6 weeks, 6 months | MVV: less LRR, less pain at day 8 and 6 weeks, better SLR at day 8 | Pro MMV |